[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ID24827A - Metoda peningkatan volume tulang dengan menggunakan agonis fp selektif yang terjadi secara non-alami - Google Patents

Metoda peningkatan volume tulang dengan menggunakan agonis fp selektif yang terjadi secara non-alami

Info

Publication number
ID24827A
ID24827A IDW20000637A ID20000637A ID24827A ID 24827 A ID24827 A ID 24827A ID W20000637 A IDW20000637 A ID W20000637A ID 20000637 A ID20000637 A ID 20000637A ID 24827 A ID24827 A ID 24827A
Authority
ID
Indonesia
Prior art keywords
agonists
improvement method
bone volume
volume improvement
natural selective
Prior art date
Application number
IDW20000637A
Other languages
English (en)
Indonesian (id)
Inventor
James Richard Hartke
Mark Walden Lundy
Mitchell Anthony Delong
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ID24827A publication Critical patent/ID24827A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000637A 1997-09-09 1998-09-04 Metoda peningkatan volume tulang dengan menggunakan agonis fp selektif yang terjadi secara non-alami ID24827A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5830697P 1997-09-09 1997-09-09

Publications (1)

Publication Number Publication Date
ID24827A true ID24827A (id) 2000-08-24

Family

ID=22015996

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000637A ID24827A (id) 1997-09-09 1998-09-04 Metoda peningkatan volume tulang dengan menggunakan agonis fp selektif yang terjadi secara non-alami

Country Status (20)

Country Link
US (1) US6156799A (no)
EP (1) EP1045694A1 (no)
JP (1) JP2001515864A (no)
KR (1) KR20010023840A (no)
CN (1) CN1269721A (no)
AR (1) AR013479A1 (no)
AU (1) AU739275B2 (no)
BR (1) BR9811780A (no)
CA (1) CA2303800A1 (no)
CO (1) CO4980882A1 (no)
HU (1) HUP0004581A2 (no)
ID (1) ID24827A (no)
IL (1) IL134760A0 (no)
NO (1) NO20001171L (no)
PE (1) PE119099A1 (no)
PL (1) PL339288A1 (no)
SK (1) SK3412000A3 (no)
TR (1) TR200000662T2 (no)
WO (1) WO1999012551A1 (no)
ZA (1) ZA988228B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1158969A2 (en) * 1999-03-05 2001-12-05 The Procter & Gamble Company Use of a non-naturally-occurring ep1 selective agonist for increasing bone volume
AU3385900A (en) * 1999-03-05 2000-09-21 Procter & Gamble Company, The Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives
DE60015508T2 (de) 1999-03-05 2005-04-21 Univ Durham C-16 ungesätigte fp-selektive prostaglandin analoge
DE60016181T2 (de) * 1999-03-05 2005-04-14 Duke University C-16 ungesätigte fp-selektive prostaglandin analoge
CA2303060A1 (en) * 1999-04-14 2000-10-14 United States Gear Corporation Towed vehicle brake controller
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US6904123B2 (en) 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
CN1498385A (zh) 2000-08-29 2004-05-19 X图像量析的方法与装置
US7467892B2 (en) 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
US7660453B2 (en) 2000-10-11 2010-02-09 Imaging Therapeutics, Inc. Methods and devices for analysis of x-ray images
US8639009B2 (en) 2000-10-11 2014-01-28 Imatx, Inc. Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
US8000766B2 (en) 2001-05-25 2011-08-16 Imatx, Inc. Methods to diagnose treat and prevent bone loss
DK1417975T3 (da) 2001-07-23 2011-04-18 Ono Pharmaceutical Co Middel til behandling af sygdomme, med tab af knoglemasse som følge, med EP4-agonist som aktivt indholdsstof
CN1893977B (zh) * 2001-07-23 2012-12-05 小野药品工业株式会社 以ep4激动剂为活性成分的治疗与骨质损失有关的疾病的药物
CA2475253A1 (en) * 2002-02-07 2003-09-04 Kathryn E. Urich Therapeutical polyanhydride compounds for drug delivery
US8965075B2 (en) 2002-09-16 2015-02-24 Imatx, Inc. System and method for predicting future fractures
US8600124B2 (en) 2004-09-16 2013-12-03 Imatx, Inc. System and method of predicting future fractures
US7840247B2 (en) 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
WO2004086972A2 (en) 2003-03-25 2004-10-14 Imaging Therapeutics, Inc. Methods for the compensation of imaging technique in the processing of radiographic images
EP1663002A4 (en) * 2003-09-19 2007-11-28 Imaging Therapeutics Inc BONE STRUCTURE PROGNOSTIC METHOD AND SIMULATED BONE REMODELING
US8290564B2 (en) 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
US20080058613A1 (en) * 2003-09-19 2008-03-06 Imaging Therapeutics, Inc. Method and System for Providing Fracture/No Fracture Classification
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
AU3607293A (en) * 1992-02-05 1993-09-03 Merck & Co., Inc. Implant therapy for bone growth stimulation
US5310759A (en) * 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US5747660A (en) * 1995-11-06 1998-05-05 The University Of Colorado Nucleic acid encoding prostaglandin F2α receptor regulatory protein
US5703108A (en) * 1996-02-28 1997-12-30 Pfizer Inc. Bone deposition by certain prostaglandin agonists

Also Published As

Publication number Publication date
CN1269721A (zh) 2000-10-11
EP1045694A1 (en) 2000-10-25
CA2303800A1 (en) 1999-03-18
AU739275B2 (en) 2001-10-11
WO1999012551A1 (en) 1999-03-18
TR200000662T2 (tr) 2000-07-21
IL134760A0 (en) 2001-04-30
SK3412000A3 (en) 2000-12-11
PE119099A1 (es) 2000-02-03
NO20001171D0 (no) 2000-03-07
BR9811780A (pt) 2000-09-12
NO20001171L (no) 2000-05-09
AU9219298A (en) 1999-03-29
JP2001515864A (ja) 2001-09-25
AR013479A1 (es) 2000-12-27
HUP0004581A2 (hu) 2001-05-28
ZA988228B (en) 1999-03-09
US6156799A (en) 2000-12-05
KR20010023840A (ko) 2001-03-26
CO4980882A1 (es) 2000-11-27
PL339288A1 (en) 2000-12-04

Similar Documents

Publication Publication Date Title
ID24827A (id) Metoda peningkatan volume tulang dengan menggunakan agonis fp selektif yang terjadi secara non-alami
ATE215369T1 (de) Carbazolanaloge als selektive beta3-adrenergische agonisten
SG120070A1 (en) File operating method
ATE324839T1 (de) Einstufiges implantatsystem
DE69739924D1 (de) Zahnimplantatsystem
MXPA01002240A (es) Tratamiento selectvio de receptores de somatostatina endoteliales.
DE69826451D1 (de) Anästehischer knochenzement
EP1095159A4 (en) Bone Morphogenetic Protein
EP1121147A4 (en) BIOLOGICALLY ACTIVE MUCOSAL ADJUVANTS SUBSTANTIALLY NON-TOXIC IN VERTEBRATES
GB9828642D0 (en) Process slaughtering fish
DE69914264D1 (de) Knochenregenerierungsmaterial
DE69709501D1 (de) Kollagenmischung
IS4743A (is) Búnaður til að fjarlægja bein, einkum fiskbein
NO20000239D0 (no) Apparat for uttrekking av fiskeben
GB9823900D0 (en) Vibratory system
FI981338A0 (fi) Menetelmä multikomponentti-alfa-interferonin valmistamiseksi
FR2720419B1 (fr) Bloc artificiel.
GB9928097D0 (en) Artificial fire apparatus
ID24759A (id) Metoda untuk meningkatkan volume tulang
EP1030608A4 (en) SURGICAL SAW AND RELATED METHODS
PL313987A1 (en) Fluoxetin obtained method
NO964545D0 (no) Benprotese
GB9811201D0 (en) Tendon support cylinder
SE9801042D0 (sv) System 870-122 konstgjord tobak
EG21375A (en) Artificial musscles